Loading...

501 posters, 2 videos, 1 audios, 8 topics, 37 sessions, 395 authors, 307 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

23rd Annual Pain Medicine Meeting 2024

November 21-23, 2024 | Caesars Palace, Las Vegas, Nevada

23rd Annual Pain Medicine Meeting 2024 banner

6201

USE OF 60-DAY PERCUTANEOUS PNS FOR SACROILIAC (SI) JOINT PAIN: A RETROSPECTIVE REVIEW OF REAL-WORLD OUTCOMES

Poster Presenter

Meredith McGee

Part of Topic

Scientific Abstracts > Chronic Pain

Use of 60 day Percutaneous PNS for Sacroiliac (SI) Joint Pain: A Retrospective Review of Real World Outcomes

Samir Sheth, MD1, Jonathan Kost, MD2, Ameet Nagpal, MD3, Marc Huntoon, MD4, Meredith McGee, PhD4, Joseph Boggs, PhD4

1. Sutter Roseville Medical Center, Roseville, CA; 2. Hartford Hospital Pain Treatment Center, Hartford, CT; 3. Medical University of South Carolina, Charleston, SC; 4. SPR Therapeutics, Inc., Cleveland, OH


BACKGROUND

• Approximately 15-30% of patients with low back pain have sacroiliac (SI) joint dysfunction as a factor1. SI JOINT PAIN

• 60-Day peripheral nerve stimulation (PNS) of the lumbar medial branches has been effective in providing long-term relief of axial low back pain2,3, but patients with SI joint pain were not included in those studies.

• Given the growing need for non-destructive, non-surgical treatments to better manage SI joint pain4, 60-day PNS may be well-suited to target the neural innervation of the SI joint.

This report details a retrospective review of real-world data from the use of Percutaneous 60-Day Peripheral Nerve Stimulation for the treatment of SI joint pain.

CONCLUSIONS

• This retrospective study found that most patients with SI joint pain achieved clinically significant pain reduction and/or improvement in quality of life, suggesting that 60-Day PNS may be an effective non-destructive, non-surgical treatment option for patients with SI joint pain.

• Targeting the middle cluneal nerves (which may also be described as the sacral lateral branches) produced the best outcomes (81% responder rate, avg. 69% relief among responders) with 60-Day PNS for patients with SI joint pain.


23rd Annual Pain Medicine Meeting 2024 » banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.